Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21

Gary W. Arendash, Gregory John Sengstock, Paul R. Sanberg, William R. Kem

Research output: Contribution to journalArticle

193 Citations (Scopus)

Abstract

The ability of two synthetic nicotine receptor ligands, GTS-21 and DMAB, to chronically enhance the cognitive function of aged rats was evaluated in three diverse tasks and compared to the cognition-enhancing effects of nicotine administration. 15 min prior to daily behavioral testing, aged 22-24 month old rats received an i.p. injection of nicotine (0.2 mg/kg), GTS-21 (1 mg/kg), DMAB (2 mg/kg), or saline vehicle and were tested in either one-way active avoidance pole jumping, Lashley III maze, or a 17-arm radial maze. GTS-21 pretreatment was as effective as nicotine for enhancing the acquisition of aged rats in both one-way active avoidance and Lashley III maze training. In 17-arm radial maze testing, GTS-21 improved both general learning and reference (long-term) memory to the same extent as nicotine. Although DMAB pretreatment enhanced reference memory in 17-arm radial maze testing to the same extent as nicotine, it did not affect general learning in this complex task and did not exert any cognition-enhancing effects in Lashley III maze training. These results indicate that GTS-21 has cognition-enhancing abilities in aged rats that are comparable to those of nicotine in a variety of behavioral tasks. Since GTS-21 acts preferentially on brain nicotinic receptors and is less toxic than nicotine, these results further indicate that GTS-21 may have substantive therapeutic value in the treatment of age-associated memory impairment (AAMI) and/or Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)252-259
Number of pages8
JournalBrain Research
Volume674
Issue number2
DOIs
StatePublished - Mar 20 1995

Fingerprint

Nicotinic Agonists
Nicotinic Receptors
Nicotine
Learning
Cognition
Aptitude
Artificial Receptors
Long-Term Memory
3-(2,4-dimethoxybenzylidene)anabaseine
Poisons
Alzheimer Disease
Ligands
Injections

Keywords

  • Acetylcholine
  • Age-associated memory impairment
  • Aging
  • Cognition-enhancing
  • Nicotine
  • Nicotinic agonist
  • Rat

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. / Arendash, Gary W.; Sengstock, Gregory John; Sanberg, Paul R.; Kem, William R.

In: Brain Research, Vol. 674, No. 2, 20.03.1995, p. 252-259.

Research output: Contribution to journalArticle

Arendash, Gary W. ; Sengstock, Gregory John ; Sanberg, Paul R. ; Kem, William R. / Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. In: Brain Research. 1995 ; Vol. 674, No. 2. pp. 252-259.
@article{228e3ba9bea548bc8e954d32a21264ad,
title = "Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21",
abstract = "The ability of two synthetic nicotine receptor ligands, GTS-21 and DMAB, to chronically enhance the cognitive function of aged rats was evaluated in three diverse tasks and compared to the cognition-enhancing effects of nicotine administration. 15 min prior to daily behavioral testing, aged 22-24 month old rats received an i.p. injection of nicotine (0.2 mg/kg), GTS-21 (1 mg/kg), DMAB (2 mg/kg), or saline vehicle and were tested in either one-way active avoidance pole jumping, Lashley III maze, or a 17-arm radial maze. GTS-21 pretreatment was as effective as nicotine for enhancing the acquisition of aged rats in both one-way active avoidance and Lashley III maze training. In 17-arm radial maze testing, GTS-21 improved both general learning and reference (long-term) memory to the same extent as nicotine. Although DMAB pretreatment enhanced reference memory in 17-arm radial maze testing to the same extent as nicotine, it did not affect general learning in this complex task and did not exert any cognition-enhancing effects in Lashley III maze training. These results indicate that GTS-21 has cognition-enhancing abilities in aged rats that are comparable to those of nicotine in a variety of behavioral tasks. Since GTS-21 acts preferentially on brain nicotinic receptors and is less toxic than nicotine, these results further indicate that GTS-21 may have substantive therapeutic value in the treatment of age-associated memory impairment (AAMI) and/or Alzheimer's disease.",
keywords = "Acetylcholine, Age-associated memory impairment, Aging, Cognition-enhancing, Nicotine, Nicotinic agonist, Rat",
author = "Arendash, {Gary W.} and Sengstock, {Gregory John} and Sanberg, {Paul R.} and Kem, {William R.}",
year = "1995",
month = "3",
day = "20",
doi = "10.1016/0006-8993(94)01449-R",
language = "English (US)",
volume = "674",
pages = "252--259",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21

AU - Arendash, Gary W.

AU - Sengstock, Gregory John

AU - Sanberg, Paul R.

AU - Kem, William R.

PY - 1995/3/20

Y1 - 1995/3/20

N2 - The ability of two synthetic nicotine receptor ligands, GTS-21 and DMAB, to chronically enhance the cognitive function of aged rats was evaluated in three diverse tasks and compared to the cognition-enhancing effects of nicotine administration. 15 min prior to daily behavioral testing, aged 22-24 month old rats received an i.p. injection of nicotine (0.2 mg/kg), GTS-21 (1 mg/kg), DMAB (2 mg/kg), or saline vehicle and were tested in either one-way active avoidance pole jumping, Lashley III maze, or a 17-arm radial maze. GTS-21 pretreatment was as effective as nicotine for enhancing the acquisition of aged rats in both one-way active avoidance and Lashley III maze training. In 17-arm radial maze testing, GTS-21 improved both general learning and reference (long-term) memory to the same extent as nicotine. Although DMAB pretreatment enhanced reference memory in 17-arm radial maze testing to the same extent as nicotine, it did not affect general learning in this complex task and did not exert any cognition-enhancing effects in Lashley III maze training. These results indicate that GTS-21 has cognition-enhancing abilities in aged rats that are comparable to those of nicotine in a variety of behavioral tasks. Since GTS-21 acts preferentially on brain nicotinic receptors and is less toxic than nicotine, these results further indicate that GTS-21 may have substantive therapeutic value in the treatment of age-associated memory impairment (AAMI) and/or Alzheimer's disease.

AB - The ability of two synthetic nicotine receptor ligands, GTS-21 and DMAB, to chronically enhance the cognitive function of aged rats was evaluated in three diverse tasks and compared to the cognition-enhancing effects of nicotine administration. 15 min prior to daily behavioral testing, aged 22-24 month old rats received an i.p. injection of nicotine (0.2 mg/kg), GTS-21 (1 mg/kg), DMAB (2 mg/kg), or saline vehicle and were tested in either one-way active avoidance pole jumping, Lashley III maze, or a 17-arm radial maze. GTS-21 pretreatment was as effective as nicotine for enhancing the acquisition of aged rats in both one-way active avoidance and Lashley III maze training. In 17-arm radial maze testing, GTS-21 improved both general learning and reference (long-term) memory to the same extent as nicotine. Although DMAB pretreatment enhanced reference memory in 17-arm radial maze testing to the same extent as nicotine, it did not affect general learning in this complex task and did not exert any cognition-enhancing effects in Lashley III maze training. These results indicate that GTS-21 has cognition-enhancing abilities in aged rats that are comparable to those of nicotine in a variety of behavioral tasks. Since GTS-21 acts preferentially on brain nicotinic receptors and is less toxic than nicotine, these results further indicate that GTS-21 may have substantive therapeutic value in the treatment of age-associated memory impairment (AAMI) and/or Alzheimer's disease.

KW - Acetylcholine

KW - Age-associated memory impairment

KW - Aging

KW - Cognition-enhancing

KW - Nicotine

KW - Nicotinic agonist

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0028934741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028934741&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)01449-R

DO - 10.1016/0006-8993(94)01449-R

M3 - Article

C2 - 7796104

AN - SCOPUS:0028934741

VL - 674

SP - 252

EP - 259

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -